Literature DB >> 11094988

Treatment of nausea and vomiting in advanced cancer.

M P Davis1, D Walsh.   

Abstract

Nausea and vomiting unrelated to chemotherapy is common in advanced cancer patients. The etiology of nausea and vomiting may from evident by the pattern of vomiting, associated symptoms, review of medications and physical examination. Radiographic studies are particularly helpful if bowel obstruction is suspected or central nervous system metastases are a possibility. Laboratory studies are helpful in a minority of cases. Multiple classes of medications are available to palliate nausea and vomiting. Classes of agents are discussed, pharmacology and cost being among the aspects covered. A four-step approach to the medical management of nausea and vomiting is presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094988     DOI: 10.1007/s005200000151

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  14 in total

Review 1.  [Use of cannabinoids for chemotherapy-induced nausea and vomiting].

Authors:  Désirée Louise Dräger
Journal:  Urologe A       Date:  2018-01       Impact factor: 0.639

Review 2.  [Symptoms involving the gastrointestinal tract].

Authors:  M Stahl; M Kloke
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

3.  Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients.

Authors:  Wadih Rhondali; Sriram Yennurajalingam; Gary Chisholm; Jeanette Ferrer; Sun Hyun Kim; Jung Hun Kang; Marilene Filbet; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2013-04-16       Impact factor: 3.603

Review 4.  Palliative Care and Symptom Management in Older Patients with Cancer.

Authors:  Koshy Alexander; Jessica Goldberg; Beatriz Korc-Grodzicki
Journal:  Clin Geriatr Med       Date:  2015-10-17       Impact factor: 3.076

Review 5.  Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.

Authors:  Paul Glare; Glenn Pereira; Linda J Kristjanson; Martin Stockler; Martin Tattersall
Journal:  Support Care Cancer       Date:  2004-04-24       Impact factor: 3.603

Review 6.  [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Authors:  G Benze; B Alt-Epping; A Geyer; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

7.  Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.

Authors:  Masashi Ishihara; Hirotoshi Iihara; Shinji Okayasu; Koji Yasuda; Katsuhiko Matsuura; Masumi Suzui; Yoshinori Itoh
Journal:  Support Care Cancer       Date:  2009-11-18       Impact factor: 3.603

8.  Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.

Authors:  S Wirz; H C Wartenberg; J Nadstawek
Journal:  Support Care Cancer       Date:  2007-12-20       Impact factor: 3.603

9.  Undertreatment of nausea and other symptoms in hospitalized cancer patients.

Authors:  Judi Greaves; Paul Glare; Linda J Kristjanson; Martin Stockler; Martin H N Tattersall
Journal:  Support Care Cancer       Date:  2008-10-18       Impact factor: 3.603

10.  Sublingually administered scopolamine for nausea in terminally ill cancer patients.

Authors:  Kengo Imai; Masayuki Ikenaga; Tomoyuki Kodama; Seitetsu Kanemura; Keiko Tamura; Tatsuya Morita
Journal:  Support Care Cancer       Date:  2013-05-31       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.